Post-Renal Transplant Plasma Cell Dyscrasia Presenting as Retroperitoneal Plasmacytoma: A Case Report and Literature Review

被引：0

作者：

Muzaffar, Mahvish ^{[1
]}

Chaudhary, Rekha ^{[1
]}

Li, Xin ^{[2
]}

Ratnam, Shobha ^{[1
]}

机构：

[1] Univ Toledo, Med Ctr, Dept Internal Med, Toledo, OH 43606 USA

[2] Univ Toledo, Med Ctr, Dept Pathol, Toledo, OH 43606 USA

来源：

DIALYSIS & TRANSPLANTATION | 2011年 / 40卷 / 03期

关键词：

POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; SOLITARY EXTRAMEDULLARY PLASMACYTOMA; RENAL-TRANSPLANT; MULTIPLE-MYELOMA; PATIENT; DISEASE;

D O I：

10.1002/dat.20539

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

Post-transplant lymphoproliferative disease (PTLD) is a rare but potentially fatal complication of organ transplantation. Most cases of PTLD represent Epstein Barr virus (EBV)-related B-cell disease in a setting of pharmacological immunosuppression. Post-transplant plasma cell dyscrasia is very rare, and post-transplant plasma cell dyscrasia with extramedullary plasmacytoma is extremely rare. We report here a case of the latter, which to our knowledge is the fourth such reported case in the English literature. A 22-year-old man developed post-transplant plasma cell dyscrasia 20 years after a renal transplant while on immunosuppression. His presentation included retroperitoneal plasmacytoma, which is very rare and is probably the first case in a renal transplant patient. The patient is in complete remission 1 year after receiving five cycles of bortezomib and dexamethasone.

引用

页码：130 / 132

页数：3

共 18 条

[1]

CACCIOLA E, 1994, HAEMATOLOGICA, V79, P73

[2] Mveloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: Characteristics, risk factors and prognosis [J].